How might the repricing influence analyst earnings forecasts and target price revisions for Waystar?

The loan‑re‑pricing essentially cuts Waystar’s financing cost and expands its balance‑sheet headroom. By lowering the effective interest rate on the first‑lien term loan and extending the amortisation schedule, the company can free‑up cash that would otherwise go to debt service. That extra cash flow translates into a higher “de‑leverage” capacity, which analysts will likely model as a modest uplift to operating earnings (e.g., a 2‑3 % lift to FY‑2025‑2026 EPS) and a tighter net‑debt/EBITDA ratio. Because the discount rate used in DCF models will be reduced by a few‑basis‑point points, the present‑value of future cash flows rises, prompting many sell‑side houses to lift their earnings forecasts and bump the implied 12‑month target price by roughly 5‑8 % (from the current $12‑$13 range to the $13‑$14 band).

From a market‑technical perspective, the news should generate a short‑covering rally and a break of the recent $12 resistance level, especially on higher‑than‑average volume. Traders can look for a bullish continuation pattern (e.g., a higher‑high, higher‑low formation) on the daily chart; a breach of $13 would validate the analyst‑driven target revisions and could attract momentum‑play buying. Conversely, investors should monitor any forward‑looking guidance from management—if Waystar signals that the repricing is a one‑off event rather than a sustained cost‑saving trend, the upside may be capped. In short, the repricing is a catalyst for upward earnings‑forecast adjustments and modest target‑price upgrades, making a long‑or‑add stance on WAY attractive at current levels, with a price‑target range of $13‑$14 as the primary upside scenario.